SeaStar Medical
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, SeaStar Medical sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).
SeaStar Medical: 6 sponsored US clinical trials, 3 recruiting.
SeaStar Medical sponsors 6 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 2 completed. The most-studied condition in this pipeline is Acute Kidney Injury, with 2 trials.
Upper-quartile sponsor footprint
SeaStar Medical sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
6 total, page 1 of 1
Feasibility of the SCD in Cardiorenal Syndrome Patients Awaiting LVAD
NCT03836482
QUELIMMUNE (SCD-PED) PediAtric SurVeillance REgistry
NCT06517810
Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury
NCT05758077
Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-19 Infections
NCT04395911
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
NCT01400893
Safety Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Renal Failure
NCT01072682
Therapeutic Areas
What is open in the SeaStar Medical pipeline
3 recruiting of 6 indexed (50% open); 2 completed (33%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Acute Kidney Injury (2 trials), 1 other listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
SeaStar Medical: open-pipeline peers nationwide
Peers matched on 6 registered trials and 50% open enrollment, not the therapeutic-area sidebar.
SeaStar Medical sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 6 trials (± recruiting share)
- 23andMe · 6 trials · 0% recruiting
- Aardvark Therapeutics · 6 trials · 0% recruiting
- Abbisko Therapeutics Co · 6 trials · 67% recruiting
- AbGenomics B.V Taiwan Branch · 6 trials · 0% recruiting
Sponsors near 50% open enrollment (± trial volume)
- 1200 Pharma · 50% recruiting · 2 trials
- 1ST Biotherapeutics · 50% recruiting · 2 trials
- 3ive Labs · 50% recruiting · 2 trials
- 60 Degrees Pharmaceuticals · 50% recruiting · 4 trials
Related
What to do with this SeaStar Medical page
6 registered trials is a research-attention snapshot, not an endorsement of SeaStar Medical or any single study.
- 3 of SeaStar Medical's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Acute Kidney Injury is the condition SeaStar Medical studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Acute Kidney Injury trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. SeaStar Medical pipeline card: 6 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.